Human medicines European public assessment report (EPAR): mResvia, respiratory syncytial virus mRNA vaccine, Date of authorisation: 22/08/2024, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Date of authorisation: 22/04/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Ayvakyt, avapritinib, Date of authorisation: 24/09/2020, Revision: 12, Status: Authorised

Agenda - European Medicines Agency workshop on bacteriophage therapy

Highlight report - Combination Products Operational Group (COMBO) - In Vitro Diagnostics stream - October 2026

EMA closed on All Souls' Day, 2 November

Human medicines European public assessment report (EPAR): Casgevy, exagamglogene autotemcel, Date of authorisation: 09/02/2024, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Sogroya, somapacitan, Date of authorisation: 31/03/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR): Micardis, telmisartan, Date of authorisation: 16/12/1998, Revision: 32, Status: Authorised

Human medicines European public assessment report (EPAR): Tafamidis Accord, tafamidis, Date of authorisation: 18/09/2026, Revision: 1, Status: Authorised